23andMe’s weekend bankruptcy filing has ignited concerns among consumers who provided the company with their genetic information and reignited discussions on data privacy among policymakers and ...
In a deal raising significant privacy concerns, biotechnology giant Regeneron Pharmaceuticals announced Monday it is acquiring embattled consumer genetics company 23andMe out of bankruptcy for $256 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results